Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €3.00 EUR
Change Today +0.008 / 0.27%
Volume 0.0
As of 3:44 PM 09/3/15 All times are local (Market data is delayed by at least 15 minutes).

qlt inc (QLT) Snapshot

Open
€2.98
Previous Close
€3.00
Day High
€3.06
Day Low
€2.98
52 Week High
09/12/14 - €5.01
52 Week Low
12/17/14 - €2.66
Market Cap
158.7M
Average Volume 10 Days
5.0
EPS TTM
--
Shares Outstanding
52.8M
EX-Date
06/28/13
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for QLT INC (QLT)

qlt inc (QLT) Related Businessweek News

No Related Businessweek News Found

qlt inc (QLT) Details

QLT Inc., a biotechnology company, engages in the development and commercialization of ocular products that address the unmet medical needs of patients and clinicians worldwide. The company focuses on the development of QLT091001, a synthetic retinoid compound, which has been completed Phase Ib retreatment clinical trials for the treatment of leber congenital amaurosis and retinitis pigmentosa; Phase Ib clinical trials for the treatment of Retinitis Pigmentosa with autosomal dominant mutation in RPE65; and Phase IIa clinical trials for the treatment of impaired dark adaptation. QLT Inc. was founded in 1981 and is headquartered in Vancouver, Canada.

31 Employees
Last Reported Date: 02/26/15
Founded in 1981

qlt inc (QLT) Top Compensated Officers

Interim Chief Executive Officer and Director
Total Annual Compensation: $94.4K
Compensation as of Fiscal Year 2014.

qlt inc (QLT) Key Developments

QLT Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2015

QLT Inc. reported unaudited consolidated earnings results for the second quarter and six months ended June 30, 2015. For the quarter, the company reported operating loss of $10,737,000 compared to $8,578,000 a year ago. Loss from continuing operations before income taxes was $10,746,000 compared to $8,558,000 a year ago. Net loss and comprehensive loss was $10,751,000 or $0.21 per basic and diluted share compared to $8,638,000 or $0.17 per basic and diluted share a year ago. The net $2.2 million increase in operating losses was primarily due to the increase in consulting and advisory fees associated with exploration and pursuit of the multiple strategic transactions. The increased net loss per share was primarily due to the increase in consulting and advisory fees related to the strategic transactions. For the quarter, the company reported operating loss of $16,752,000 compared to $16,349,000 a year ago. Loss from continuing operations before income taxes was $16,633,000 compared to $14,805,000 a year ago. Net loss and comprehensive loss was $16,647,000 or $0.32 per basic and diluted share compared to $15,100,000 or $0.29 per basic and diluted share a year ago.

InSite Vision Incorporated, QLT Inc. - M&A Call

To discuss acquisition of InSite Vision Incorporated in an all-stock transaction that will create an ophthalmic specialty pharmaceutical company with a diversified portfolio of products, full R&D capabilities and innovative platform technologies

QLT Inc. Reports Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2015

QLT Inc. reported unaudited consolidated earnings results for the first quarter ended March 31, 2015. For the quarter, the company reported operating loss of USD 6.015 million compared to USD 7.769 million a year ago. Loss before income taxes was USD 5.887 million compared to USD 6.247 million a year ago. Net loss and comprehensive loss was USD 5.896 million compared to USD 6.462 million a year ago. Basic and diluted loss per share was USD 0.12 compared to USD 0.13 a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
QLT:GR €3.00 EUR +0.008

QLT Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for QLT.
View Industry Companies
 

Industry Analysis

QLT

Industry Average

Valuation QLT Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book 1.2x
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact QLT INC, please visit www.qltinc.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.